Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|
| Total revenue | 13.60%162.26K | 423.44%142.83K | 372.73%27.29K | -46.98%5.77K | 10.89K |
| Operating revenue | 13.60%162.26K | 423.44%142.83K | 372.73%27.29K | -46.98%5.77K | --10.89K |
| Cost of revenue | |||||
| Gross profit | 13.60%162.26K | 423.44%142.83K | 372.73%27.29K | -46.98%5.77K | 10.89K |
| Operating expense | 10.18%3.01M | 16.96%2.73M | -7.39%2.34M | -27.78%2.52M | 3.49M |
| Selling and administrative expenses | -27.40%1.4M | 31.54%1.93M | -13.98%1.47M | -23.56%1.7M | --2.23M |
| -Selling and marketing expense | -44.42%143.29K | 136.59%257.81K | --108.97K | ---- | ---- |
| -General and administrative expense | -24.78%1.26M | 23.11%1.67M | -20.37%1.36M | -23.56%1.7M | --2.23M |
| Research and development costs | 151.26%871.31K | 60.28%346.78K | 83.26%216.36K | -77.52%118.06K | --525.11K |
| Depreciation amortization depletion | 16.33%4.62K | --3.97K | ---- | -26.49%57.75K | --78.56K |
| -Depreciation and amortization | 16.33%4.62K | --3.97K | ---- | -26.49%57.75K | --78.56K |
| Provision for doubtful accounts | ---- | ---- | ---- | ---- | --4.19K |
| Other operating expenses | 62.09%735.3K | -30.66%453.65K | 1.74%654.22K | -2.01%643.03K | --656.24K |
| Operating profit | -10.00%-2.85M | -12.16%-2.59M | 8.27%-2.31M | 27.72%-2.52M | -3.48M |
| Net non-operating interest income (expenses) | -544.92%-75.34K | 63.92%-11.68K | 24.72%-32.38K | -266.69%-43.01K | -11.73K |
| Non-operating interest income | ---- | ---- | ---- | -71.98%2.05K | --7.31K |
| Non-operating interest expense | 544.92%75.34K | -63.92%11.68K | -28.14%32.38K | 136.72%45.06K | --19.04K |
| Other net income (expenses) | 81.25%643.73K | -58.91%355.17K | -27.66%864.4K | 282.91%1.19M | 312.06K |
| Special income (charges) | ---- | ---- | ---- | 86.91%-119.11K | ---909.8K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | -86.91%119.11K | --909.8K |
| Other non-operating income (expenses) | 81.25%643.73K | -58.91%355.17K | -34.22%864.4K | 7.54%1.31M | --1.22M |
| Income before tax | -1.69%-2.28M | -51.80%-2.24M | -8.19%-1.48M | 57.09%-1.37M | -3.18M |
| Income tax | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||||
| Net income | -1.69%-2.28M | -82.30%-2.24M | 9.91%-1.23M | 57.09%-1.37M | -3.18M |
| Net income continuous operations | -1.69%-2.28M | -51.80%-2.24M | -8.19%-1.48M | 57.09%-1.37M | ---3.18M |
| Net income discontinuous operations | ---- | ---- | --247.14K | ---- | ---- |
| Noncontrolling interests | 39.65%-14.92K | -24.72K | |||
| Net income attributable to the company | -1.69%-2.28M | -82.30%-2.24M | 8.92%-1.23M | 57.23%-1.35M | -3.16M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | |||||
| Net income attributable to common stockholders | -1.69%-2.28M | -82.30%-2.24M | 8.92%-1.23M | 57.23%-1.35M | -3.16M |
| Diluted earnings per share | 56.88%-0.069 | -36.36%-0.16 | 58.49%-0.1173 | 71.73%-0.2827 | -1 |
| Basic earnings per share | 56.88%-0.069 | -36.36%-0.16 | 58.49%-0.1173 | 71.73%-0.2827 | -1 |
| Dividend per share | |||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |